Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
stevepb / Pixabay

Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial

According to a story from news.cision.com, the Swedish biotechnology company Cyxone recently announced positive results from the company's phase 1 clinical trial. This trial was testing the tolerability and safety…

Continue Reading Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh
Pexels / Pixabay

NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh

According to a publication from NewZNew, the NeuroGen Brain and Spine Institute in India plans on hosting an outpatient stem cell therapy consultation camp in Chandigarh on the last day…

Continue Reading NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh
Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis
allinonemovie / Pixabay

Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis

According to a story from BioPortfolio, a team of scientists associated with the University of Zurich and others have made a remarkable discovery that could reveal new information about the…

Continue Reading Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis

This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

  As reported recently in PhysOrg by NASA, researchers aboard SpaceX CRS-18 cargo flight are focusing on what triggers Parkinson’s disease and multiple sclerosis, both neurodegenerative diseases. Researchers suspect that…

Continue Reading This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

  While the last few years have seen major advances in all areas of the pharmaceutical industry, some of the newest and brightest talents are now focusing on cell and…

Continue Reading A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

  The number of people in the U.S. who are permanently disabled or who die each year as a result of misdiagnosis is estimated to be over 100,000. EurekAlert recently reported…

Continue Reading Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment

Heather White Heather White is a 41-year-old woman who was diagnosed with common variable immune deficiency (CVID) back in 2004 after fighting frequent bouts of pneumonia. Doctors believe that she…

Continue Reading A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment

New Bill Could Allow Easier Access to Complex Rehabilitation Technology for Rare Disease Patients

H.R. 2408 H.R. 2408 is a new piece of federal legislation otherwise known as the "Ensuring Access to Quality Complex Rehabilitation Technology Act." Essentially, this act creates a new category…

Continue Reading New Bill Could Allow Easier Access to Complex Rehabilitation Technology for Rare Disease Patients
This Neurologist is Committed to Developing New Therapies for Multiple Sclerosis, but Challenges Lie Ahead
mwooten / Pixabay

This Neurologist is Committed to Developing New Therapies for Multiple Sclerosis, but Challenges Lie Ahead

According to a story from CityScene, Ohio State University's Dr. Michael Racke is considered one of the country's cutting edge researchers in the field of multiple sclerosis treatment. He is…

Continue Reading This Neurologist is Committed to Developing New Therapies for Multiple Sclerosis, but Challenges Lie Ahead
2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases
Skitterphoto / Pixabay

2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases

According to a story from Multiple Sclerosis News Today, 2019 is the tenth year that the Multiple Sclerosis Association of America (MSAA) has conducted its Art Showcases initiative. The program…

Continue Reading 2019 Marks the 10 Year Anniversary of the Multiple Sclerosis Association of America’s Art Showcases

Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness

An Unexpected Emergency Kristin Hardy and her sister Margaret are no strangers to rare disease. Kristin has primary progressive multiple sclerosis (MS) and Margaret has relapsing-remitting multiple sclerosis. Margaret also…

Continue Reading Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness